FEG
APYX icon

Financial Enhancement Group’s Apyx Medical APYX Stock Holding History

Financial Enhancement Group’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,340
Closed -$6K – 281
2020
Q3 		$6K Buy
+1,340
New +$6.64K ﹤0.01% 179

Other funds holding APYX

RTW Investments
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PVI
Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $214M AUM 47.29% 1-Year Est. Return
Horizon Kinetics Asset Management
Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Royce & Associates
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Financial Enhancement Group's APYX Position: Q4 2020 in Review

Financial Enhancement Group sold out of Apyx Medical (APYX) in Q4 2020, closing a stake of 1,340 shares — an estimated $6K sold.

Financial Enhancement Group first reported a position in APYX in Q3 2020 and held it in 1 quarter. The position peaked at $6K in Q3 2020. 64 funds tracked by Wall St. Rank hold APYX as of Q4 2020.

  • Financial Enhancement Group reported no remaining Apyx Medical position as of Q4 2020 after selling out during the quarter.
  • Financial Enhancement Group sold 1,340 Apyx Medical shares in Q4 2020, an estimated $6K.
  • Financial Enhancement Group first reported a position in Apyx Medical in Q3 2020 and held it in 1 quarter.
  • Financial Enhancement Group's Apyx Medical position peaked at $6K in Q3 2020.
  • 64 funds tracked by Wall St. Rank held Apyx Medical as of Q4 2020.

Based on Financial Enhancement Group's 13F filing for Q4 2020, filed 10 Feb 2021.